Biodetection Diagnosing Difficult-to-detect Pathogens in Central Nervous System InfectionsGlobal Biodefense StaffNovember 13, 2024
Medical Countermeasures FDA Removes Clinical Hold on Novavax’s Combo COVID-Flu VaccineGlobal Biodefense StaffNovember 11, 2024
Medical Countermeasures GigaGen Wins BARDA Contract to Develop Biothreat CountermeasuresGlobal Biodefense StaffOctober 3, 2024
